Midatech Pharma Plc announced that it has entered into a four-year senior secured loan agreement with MidCap Financial of up to $15 million. Midatech has received an initial tranche of $7 million. The issuance of further tranches under the Facility is dependent on clinical development milestones set out for MTD201 and MTX110. The funds will be used to support progression towards these and other value-driving product milestones.